Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)

Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia: study protocol for a randomised controlled trial (PARROT-2)

Abstract Background Pre-eclampsia is a complex pregnancy disorder, characterised by new or worsening hypertension associated with multi-organ dysfunction. Adverse outcomes include eclampsia, liver rupture, stroke, pulmonary oedema, and acute kidney injury in the mother, and stillbirth, foetal growth...

Full description

Bibliographic Details
Main Authors: Alice Hurrell, Jenie Sparkes, Kate Duhig, Paul T. Seed, Jenny Myers, Cheryl Battersby, Katherine Clark, Marcus Green, Rachael M. Hunter, Andrew H. Shennan, Lucy C. Chappell, Louise Webster
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Trials
Subjects:
Pre-eclampsia
Angiogenic biomarkers
Placental growth factor
Soluble fms-like tyrosine kinase 1
Online Access:https://doi.org/10.1186/s13063-022-06652-8

Internet

https://doi.org/10.1186/s13063-022-06652-8

Similar Items